The home infusion therapy devices market was valued USD 30.2 Billion in 2021 and is projected to reach USD 62.3 billion by 2030 at CAGR of 7.9% over the forecast period 2022-2030. Home infusion therapy devices are devices that are used to deliver medications through a needle or catheter into a vein outside the hospital or clinical setting. The growing demand for home infusion therapy devices is due to factors such as rising geriatric population and raising awareness regarding the services of home infusion.
Additionally, the growing incidence of cancer, diabetes, immune deficiencies, and infections, along with favorable reimbursement scenarios, is driving the growth of the market. For instance, according to the United Nations, the older population is likely to reach 425 million by 2050. This rise in the aging population will lead to a rise in home care as this population is highly prone to various chronic disorders and is at a higher risk of developing complications which are also likely to drive the market.
However, lack of trained manpower along with vast product recalls and lack of standard usage guidelines are the key factors limiting the growth of the market.
The home infusion therapy devices market has been segmented into product and application.
By product, the market has been segmented into infusion pumps, intravenous sets, IV cannulas, needleless connectors, elastomeric pumps, and others. The intravenous sets segment is expected to register the highest CAGR during the forecast period due to growing demand.
On the basis of application, the market has been segmented into anti-infectives, endocrinology, enteral nutrition, chemotherapy, hydration therapy, parenteral infusion, and others.
The home infusion therapy devices market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The home infusion therapy devices market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.
The European home infusion therapy devices market has been segmented into Western Europe and Eastern Europe. The Western Europe home infusion therapy devices market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The home infusion therapy devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The home infusion therapy devices market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key Players
Braun Melsungen AG, Fresenius Kabi AG, Baxter International Inc., Johnson & Johnson Private Limited, Pfizer Inc., Terumo Corporation, Smith & Nephew, Care Fusion Corporation are some of the prominent players in the home infusion therapy devices market.
Regional Market Summary
The Americas is the market leader and has an attractive market for home infusion therapy devices owing to the increasing prevalence of cardiovascular, neurological, and infections pertaining to the rising geriatric population, which is a major trigger factor. For instance, according to the US Census Bureau, in 2016, around 49.2 million residents were aged 65 and above. This huge older population led to over 15.2% of the total population, which is likely to drive the market.
Additionally, according to the Canadian Cancer Society, in 2017, an estimated 206,200 new cases of cancer and 80,800 deaths occurred in Canada. This huge older population and increasing cases of cancer are driving the home infusion devices market. Furthermore, the Americas is witnessing rampant advancements in technology, and increasing government initiatives, and funding for research in the medical devices sector is driving the market growth.
Europe accounts for the second largest market and holds a healthy share in the home infusion therapy devices market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure, and flourishing medical device industry due to the presence of major market players. Additionally, the rising prevalence of chronic disorders such as cardiovascular disorders, neurological disorders, among other disorders, is driving the growth of the market. Additionally, rising surgical procedures is driving the growth as home care is required after surgical procedures. According to the National Health Service (NHS), surgery is the most important treatment offered by the NHS in secondary care within the UK. Furthermore, in 2015, NHS estimated that there were around 4.7 million surgical admissions in England, out of which 1.3 million procedures were for general surgery and around 1.2 million procedures were for trauma and orthopedics.
Asia Pacific is expected to be the fastest growing market, owing to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, and availability of favorable insurance policies. Moreover, due to lower cost of clinical trials, research key players have been setting up their regional headquarters and manufacturing plants in Singapore, China, Japan, Korea, and Australia which make a positive growth curve in home infusion therapy devices market in future.
The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access, and availability of treatment facilities. In the Middle East, the United Arab Emirates and Saudi Arabia is the largest market share owing to the development of the healthcare industry and the rising availability of specialty care centers.
Intended Audience
| Report Attribute/Metric | Details |
| Market Size | USD 62.3 Billion |
| CAGR | 7.9% |
| Base Year | 2021 |
| Forecast Period | 2022-2030 |
| Historical Data | 2020 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product, Application, |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Braun Melsungen AG, Fresenius Kabi AG, Baxter International Inc., Johnson & Johnson Private Limited, Pfizer Inc., Terumo Corporation, Smith & Nephew, Care Fusion Corporation |
| Key Market Opportunities | New product launches and R&D Amongst major key Players |
| Key Market Drivers | · Growing incidence of cancer, diabetes, immune deficiencies, and infections · Rise in the aging population · Rise in home care |
Home Infusion Therapy Devices Market Highlights:
Frequently Asked Questions (FAQ) :
The home infusion therapy devices market is projected to grow at a 7.9% CAGR during the forecast period.
The Americas is predicted to lead the home infusion therapy devices market.
Leading players profiled in the home infusion therapy devices market include Care Fusion Corporation, Smith & Nephew, Terumo Corporation, Pfizer Inc., Johnson & Johnson Private Limited, Baxter International Inc., Fresenius Kabi AG, and Braun Melsungen AG.
Specific strategies adopted by industry players to create a foothold in the home infusion therapy devices market include joint ventures, acquisitions, R&D, and product launches.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
